MARSHALL WACE, LLP - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 88 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q1 2021. The put-call ratio across all filers is 0.04 and the average weighting 0.8%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2021$420,000
-88.5%
3,543
-88.5%
0.00%
-90.0%
Q4 2020$3,647,000
-69.7%
30,880
-71.5%
0.02%
-74.0%
Q3 2020$12,022,000
-30.1%
108,168
-35.7%
0.08%
-35.8%
Q2 2020$17,199,000
+39897.7%
168,318
+45638.6%
0.12%
Q4 2019$43,000
-99.4%
368
-99.4%
0.00%
-100.0%
Q3 2019$7,413,00064,7600.06%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q1 2021
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 131,657$13,077,0005.92%
Point72 Hong Kong Ltd 103,797$10,310,0003.49%
York Capital Management Global Advisors, LLC 827,738$82,219,0002.00%
Parametrica Management Ltd 3,889$386,0001.83%
Athos Capital Ltd 35,266$3,503,0001.19%
Hillhouse Capital Management 618,391$61,425,0001.05%
JUPITER ASSET MANAGEMENT LTD 502,812$49,940,0000.73%
Black Creek Investment Management Inc. 240,232$23,862,0000.73%
COMGEST GLOBAL INVESTORS S.A.S. 243,652$24,202,0000.54%
Temasek Holdings (Private) Ltd 990,000$98,337,0000.52%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders